Febuxostat Clinical Trials

3 actively recruiting trials

▼ -1 trial since August 2026

Also known as: Feburic, Usoric® Tab 40mg

Pipeline

Phase 1: 1Phase 4: 2

Top Sponsors

Seoul National University Hospital1
Saga University1
Fujita Health University1

Indications

Arthritis2
Uric Acid1
Gout1
Parkinson's Disease (PD)1
Parkinson's Disease1

Other3 trials

A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease

Phase 1

Effect of Dotinurad in Hyperuricemia With Hypertension

Phase 4

the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.